Skip to main content

CITADEL ADVISORS LLC

Position in SGMT — Sagimet Biosciences Inc.

CIK 1423053 MIAMI, FL

Position in SGMT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$356,203
-$17,461 QoQ
Shares Held
68,173
+8.0% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Derivatives in SGMT

reported options exposure · as of Mar 31, 2026
CallValue
$349,552
CallShares
66,900
PutValue
$395,532
PutShares
75,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names. SGMT ranks #274 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SGMT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $349,552 66,900
2026-03-31 $395,532 75,700
2026-03-31 $356,203 68,173
2025-12-31 $373,664 63,119
2025-12-31 $403,152 68,100
2025-12-31 $548,192 92,600
2025-09-30 $68,881 10,041
2025-09-30 $310,072 45,200
2025-09-30 $762,832 111,200
2025-06-30 $783,206 102,783
2025-06-30 $627,126 82,300
2025-06-30 $557,022 73,100
2025-03-31 $160,392 49,200
2025-03-31 $88,998 27,300
2025-03-31 $140,074 42,968
2024-12-31 $325,800 72,400
2024-12-31 $3,350,393 744,532
2024-12-31 $33,300 7,400
2024-09-30 $3,367,962 1,215,871
2024-09-30 $277 100
2024-09-30 $183,928 66,400
2024-06-30 $28,044 8,200
2024-06-30 $4,086,882 1,194,995
2024-06-30 $3,420 1,000
2024-03-31 $164,041 30,266
2023-09-30 $2,742,379 311,634